Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75

NCT00234494 is registered in ClinicalTrials.gov with Christopher Sweeney, MBBS as lead sponsor.

NCT NCT00234494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75
Lead sponsor
Christopher Sweeney, MBBS
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
December 31, 2008
Enrollment
45 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer